Commercial sensitivity or patient protection? Secrecy and medicine safety

Press/Media: Expert Comment


Researchers have identified an information gap between pharmacological companies and Australian clinicians on the potential safety risks of medicines.


Medication safety alerts from post-marketing surveillance varies from country to country. There is a failure to make these alerts public and there is a failure of governance at a national level.

Period8 Mar 2019

Media contributions


Media contributions